<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://purl.org/rss/1.0/"><channel rdf:about="http://www.ejvesextra.com//inpress?rss=yes"><title>EJVES Extra - Articles in Press</title><description>EJVES Extra RSS feed: Articles in Press.    The  European Journal of Vascular and Endovascular Surgery  is aimed primarily at vascular surgeons dealing with patients with 
arterial, venous and lymphatic diseases. Contributions are included on the diagnosis, investigation and management of these vascular 
disorders. Papers that consider the technical aspects of vascular surgery are encouraged, and the journal includes invited state-of-the-art 
articles.  
 
Reflecting the increasing importance of endovascular techniques in the management of vascular diseases and the value of 
closer collaboration between the vascular surgeon and the vascular radiologist, the journal has now extended its scope to encompass the 
growing number of contributions from this exciting field. Articles describing endovascular method and their critical evaluation are included, 
as well as reports on the emerging technology associated with this field.  
 
Contributions are also included from such associated specialities 
as angiology, diabetology, rehabilitation and other fundamental sciences, provided these relate to the management of vascular patients. 

 
 
 The European Society For Vascular Surgery  was founded and inaugurated on May 6, 1987 in London.  The objectives of the 
Society are to relieve sickness and to preserve and protect health by advancing for the public benefit the science and art and research 
into vascular disease including vascular surgery. 
 
To order this journal online, visit
    http://intl.elsevierhealth.com/journals/ejvs 
   </description><link>http://www.ejvesextra.com//inpress?rss=yes</link><dc:publisher>Elsevier Inc.</dc:publisher><dc:language>en</dc:language><dc:rights> © 2012 European Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved. </dc:rights><prism:publicationName>EJVES Extra</prism:publicationName><prism:issn>1533-3167</prism:issn><prism:publicationDate>2012-05-17</prism:publicationDate><prism:copyright> © 2012 European Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved. </prism:copyright><prism:rightsAgent>healthpermissions@elsevier.com</prism:rightsAgent><items><rdf:Seq><rdf:li rdf:resource="http://www.ejvesextra.com/article/PIIS1533316712000118/abstract?rss=yes"/><rdf:li rdf:resource="http://www.ejvesextra.com/article/PIIS1533316712000167/abstract?rss=yes"/><rdf:li rdf:resource="http://www.ejvesextra.com/article/PIIS1533316712000155/abstract?rss=yes"/></rdf:Seq></items></channel><item rdf:about="http://www.ejvesextra.com/article/PIIS1533316712000118/abstract?rss=yes"><title>Failure of Sweat Gland Curettage to Relieve Axillary Hyperhidrosis: A Salutary Lesson - Corrected Proof</title><link>http://www.ejvesextra.com/article/PIIS1533316712000118/abstract?rss=yes</link><description>Abstract: Introduction: Several treatment options are available for primary hyperhidrosis. Selection for individual patients is influenced by symptom severity, success rates and the relative risk of compensatory hyperhidrosis.Case report: A 24-year-old female presented with a 10-year history of palmar, pedal and axillary hyperhidrosis. Following recurrent relapse after botulinum toxin (BOTOX®) injections for axillary hyperhidrosis bilateral axillary sweat gland curettage was performed with immediate procedural success. At 6 month follow-up recurrent hyperhidrosis was reported affecting both axillae. A starch-iodine test showed a rim of persisting sweating at the periphery of both axillae.Discussion: Curettage is generally performed without specific identification of sweat gland distribution, perhaps explaining the recurrence in this patient. In contrast, a starch–iodine test is used to guide administration of BOTOX® for hyperhidrosis. We propose pre-operative use of this technique before axillary curettage.</description><dc:title>Failure of Sweat Gland Curettage to Relieve Axillary Hyperhidrosis: A Salutary Lesson - Corrected Proof</dc:title><dc:creator>S.J. Chapman, M.J. Gough</dc:creator><dc:identifier>10.1016/j.ejvsextra.2012.02.008</dc:identifier><dc:source>EJVES Extra (2012)</dc:source><dc:date>2012-05-17</dc:date><prism:publicationName>EJVES Extra</prism:publicationName><prism:publicationDate>2012-05-17</prism:publicationDate><prism:section>SHORT REPORT</prism:section></item><item rdf:about="http://www.ejvesextra.com/article/PIIS1533316712000167/abstract?rss=yes"><title>Endovascular Retrieval of Fragmented Central Venous Access Device Catheters: A Management Protocol Based on Catheter Location - Corrected Proof</title><link>http://www.ejvesextra.com/article/PIIS1533316712000167/abstract?rss=yes</link><description>Abstract: Introduction: Fragmented central venous access device (CVAD) catheters can be retrieved percutaneously but a pertinent approach for catheters in various locations has not been addressed.Report: Comparing 14 fragmented CVAD catheters managed with direct snaring with 35 catheters treated by a modified protocol with repositioning of intrapulmonary or intracardiac catheters (21/35 cases) to the inferior vena cava before snaring, the latter group had a shorter fluoroscopic time (23.0 ± 10.6 vs. 11.0 ± 4.0 min, P = 0.005) and less chest symptoms (42.8% vs. 8.7%, P = 0.011).Conclusion: Fragmented CVAD catheters managed with a modified protocol with repositioning before snaring are feasible with reductions in fluoroscopic time and chest symptoms.</description><dc:title>Endovascular Retrieval of Fragmented Central Venous Access Device Catheters: A Management Protocol Based on Catheter Location - Corrected Proof</dc:title><dc:creator>S.-F. Ko, C.-K. Sun, C.-T. Kung, S.-H. Ng, C.-C. Huang</dc:creator><dc:identifier>10.1016/j.ejvsextra.2012.03.004</dc:identifier><dc:source>EJVES Extra (2012)</dc:source><dc:date>2012-05-17</dc:date><prism:publicationName>EJVES Extra</prism:publicationName><prism:publicationDate>2012-05-17</prism:publicationDate><prism:section>SHORT REPORT</prism:section></item><item rdf:about="http://www.ejvesextra.com/article/PIIS1533316712000155/abstract?rss=yes"><title>A Case of Iatrogenic Ilio-iliac Arteriovenous Fistula Initially Mistaken for Deep Venous Thrombosis - Corrected Proof</title><link>http://www.ejvesextra.com/article/PIIS1533316712000155/abstract?rss=yes</link><description>Abstract: Deep venous thrombosis (DVT) and associated complications cause significant morbidity and mortality in orthopedic surgery. Typical DVT symptoms, such as swelling, pain and discoloration in the affected extremities are often unreliable for diagnosis. Here we report a rare case of iatrogenic ilio-iliac arteriovenous fistula (AVF) due to lumbar discectomy, which was initially misdiagnosed as DVT, resulting in unnecessary implantation of a permanent inferior vena cava filter. Endovascular treatment is an attractive treatment option for such an AVF. We recommend a thorough physical and ultrasonography for patients presenting with DVT-like symptoms, especially following lumbar spinal surgery, to prevent overlooking underlying AVF.</description><dc:title>A Case of Iatrogenic Ilio-iliac Arteriovenous Fistula Initially Mistaken for Deep Venous Thrombosis - Corrected Proof</dc:title><dc:creator>X. Liu, M. Lu, H. Shi, M. Jiang</dc:creator><dc:identifier>10.1016/j.ejvsextra.2012.03.003</dc:identifier><dc:source>EJVES Extra (2012)</dc:source><dc:date>2012-04-23</dc:date><prism:publicationName>EJVES Extra</prism:publicationName><prism:publicationDate>2012-04-23</prism:publicationDate><prism:section>SHORT REPORT</prism:section></item></rdf:RDF>
